Global analgesic medicine sales in 2024 show varied performances across countries. Australia leads with $382.1 million USD PPP, experiencing a slight growth of 1.72% from 2023. In contrast, Greece sees a decline of 2.99%, standing at $225 million. Norway shows a healthy growth of 6.81%, reaching $211.6 million. Denmark and Austria have contrasting trends, with Denmark declining by 2.37% to $134.4 million, while Austria grows by 7.25% to $124 million. Estonia, Costa Rica, and Luxembourg exhibit smaller market sizes but notable growth, with Estonia at $24.8 million (9.02% growth), Costa Rica at $15.8 million (10.02% growth), and Luxembourg at $13.4 million (7.12% growth).
Future trends to watch include the potential impact of innovations in analgesic formulations and the influence of regulatory changes in key markets. Growth in smaller markets like Costa Rica and Estonia could indicate untapped potential, while declines in countries like Greece and Denmark may signal shifting consumer preferences or economic pressures. Additionally, emerging markets and increasing demand for over-the-counter pain relief could further shape the landscape.
Top countries in Analgesic Medicine Sales by Country
| # | 8 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Australia | 382.1 | 2023 | +2.6% | +1.72% | View data |
| 2 | 2 Greece | 225 | 2023 | +3.12% | -2.99% | View data |
| 3 | 3 Norway | 211.6 | 2023 | +2.67% | +6.81% | View data |
| 4 | 4 Denmark | 134.4 | 2023 | -0.22% | -2.37% | View data |
| 5 | 5 Austria | 124 | 2023 | +6.71% | +7.25% | View data |
| 6 | 6 Estonia | 24.8 | 2023 | +5.53% | +9.02% | View data |
| 7 | 7 Costa Rica | 15.8 | 2023 | +5.33% | +10.02% | View data |
| 8 | 8 Luxembourg | 13.4 | 2023 | +4.69% | +7.12% | View data |
